Table 2 Anthropometric and laboratory parameters of all participants based on subgroup analysis by CAD and gender

Age (year)

51.63 ± 10.53

54.84 ± 8.18

0.100

52.67 ± 9.22

55.83 ± 8.87

0.093

Gender (M/F)

23/17

52/18

0.069

–

–

–

Male, n (%)

23 (57.5)

52 (74.3)

–

–

–

–

Female, n (%)

17 (42.5)

18 (25.7)

–

–

–

–

BMI (kg/m²)

25.44 ± 5.09

25.06 ± 4.20

0.674

24.14 ± 4.32

27.45 ± 4.17

< 0.001

Systolic blood pressure (mmHg)

127.22 ± 22.32

136.21 ± 20.80

0.036

128.71 ± 18.13

142.03 ± 25.88

0.008

Diastolic blood pressure (mmHg)

78.63 ± 11.36

82.34 ± 10.12

0.079

80.53 ± 10.19

81.97 ± 11.77

0.513

Blood pressure history, n (%)

15 (37.5)

30 (42.9)

0.583

26 (34.7)

19 (40.9)

0.51

Smoking, n (%)

20 (50)

45 (64.3)

0.143

50 (66.7)

15 (42.9)

0.018

Aspirin medication, n (%)

34 (85)

58 (82.9)

0.896

61 (81.3)

31 (88.6)

0.339

Statin medication, n (%)

28 (70)

51 (72.9)

0.749

51 (68)

28 (80)

0.193

ABCA1 methylation, n (%)

24 (60)

56 (80)

0.023

50 (66.7)

30 (85.7)

0.037

ABCG1 methylation, n (%)

24 (60)

29 (41.4)

0.061

33 (44)

20 (57.1)

0.199

TG (mg/dl)

102.50 (80.75–164.50)

139.50 (98.00–178.50)

0.278

132 (91–180)

134 (95–160)

0.760

Total cholesterol (mg/dl)

156.10 ± 42.55

157.50 ± 37.96

0.895

153.93 ± 39.86

163.54 ± 38.45

0.236

HDL-C (mg/dl)

41.82 ± 10.32

41.66 ± 12.64

0.946

40.35 ± 11.91

44.63 ± 11.16

0.077

LDL-C (mg/dl)

85.96 ± 38.72

84.94 ± 39.79

0.897

85.42 ± 38.73

85.07 ± 40.84

0.966

ApoA1 (mg/dl)

133.10 ± 25.25

129.38 ± 25.16

0.457

127.80 ± 25.55

137.01 ± 23.36

0.073

ApoB (mg/dl)

79.88 ± 28.35

85.31 ± 26.81

0.320

82.43 ± 25.10

85.28 ± 32.01

0.644

ApoB/ApoA1

0.62 ± 0.26

0.69 ± 0.26

0.207

0.67 ± 0.23

0.65 ± 0.31

0.698